G Hieronimi
Overview
Explore the profile of G Hieronimi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
115
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dembinski J, Arpe V, Kroll M, Bartmann P, Hieronimi G
Biol Neonate
. 2001 Oct;
80(3):210-4.
PMID: 11585984
Hypothyroxinemia in preterm infants without congenital hypothyroidism is associated with developmental delay. Longitudinal information on thyroid function in very-low-birth-weight (VLBW, <1,500 g birth weight) infants is limited: we present data...
2.
Dembinski J, Arpe V, Kroll M, Hieronimi G, Bartmann P
Arch Dis Child Fetal Neonatal Ed
. 2000 May;
82(3):F215-7.
PMID: 10794789
Background: Thyroid function disorders have often been observed in preterm infants after intravenous administration of iodinated contrast medium. The effect on thyroid function depends on the dosage, but the choice...
3.
Gortner L, Wauer R, Stock G, Reiter H, Reiss I, Jorch G, et al.
J Perinat Med
. 2000 Mar;
27(6):484-9.
PMID: 10732308
Background: There still is a controversy as to the neonatal outcome of small for gestational age (SGA) infants compared to a appropriate for gestational age (AGA) preterm infants. As a...
4.
Gortner L, Wauer R, Hammer H, Stock G, Heitmann F, Reiter H, et al.
Pediatrics
. 1998 Oct;
102(5):1153-60.
PMID: 9794948
Objective: To investigate whether early (<1 hour after birth) surfactant administration would be superior to late treatment (2-6 hours after birth) in preterm infants. Study Design: Randomized controlled multicenter clinical...
5.
Dembinski J, Kroll M, Hieronimi G
Eur J Pediatr
. 1998 Jul;
157(6):519.
PMID: 9667414
No abstract available.
6.
Maier R, Obladen M, Scigalla P, Linderkamp O, Duc G, Hieronimi G, et al.
N Engl J Med
. 1994 Apr;
330(17):1173-8.
PMID: 8139627
Background: Anemia of prematurity is characterized by low reticulocyte counts and inadequate erythropoietin response, for which many very-low-birth-weight infants receive multiple blood transfusions. We investigated whether early treatment of such...
7.
Gortner L, Pohlandt F, Bartmann P, Bernsau U, Porz F, Hellwege H, et al.
Acta Paediatr
. 1994 Feb;
83(2):135-41.
PMID: 8193488
The aim of the study was to determine if high-dose bovine surfactant (Alveofact, initially 100 mg/kg birth weight) would improve oxygenation compared with low-dose surfactant (50 mg/kg birth weight) administered...
8.
Gortner L, Bartmann P, Pohlandt F, Bernsau U, Porz F, Hellwege H, et al.
Pediatr Pulmonol
. 1992 Sep;
14(1):4-9.
PMID: 1437342
Objective: To determine the effect of bovine surfactant (SF-RI 1, Alveofact) administered during the first hour following birth to very premature infants [gestational age (GA), 25-30 weeks] in a multicenter,...
9.
Gortner L, Bartmann P, Bernsau U, Hellwege H, Hieronimi G, Jorch G, et al.
Z Geburtshilfe Perinatol
. 1992 Jul;
196(4):159-64.
PMID: 1413943
We investigated the effects of a bovine surfactant (SF-RI 1, Alveofact) in very low birth weight infants (VLBW, b.w. 500-1500 g) with established respiratory distress syndrome (RDS; definition: FiO2 greater...
10.
Gortner L, Bernsau U, Hellwege H, Hieronimi G, Jorch G, Reiter H
Dev Pharmacol Ther
. 1991 Jan;
16(1):1-6.
PMID: 1879246
The efficacy of a bovine surfactant preparation (SF-RI 1) to increase survival without bronchopulmonary dysplasia (BPD) was studied in very premature infants in a multicenter, randomized sequential trial. Thirty-four infants...